Company / Profit Margin
Amylyx Pharmaceuticals, Inc. Profit Margin History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-345.4%
FY2024
5-year range
-892.4% / 12.9%
FY2022-FY2024
Trend
-2768.9%
vs FY2023
Sector context
#118 of 146
Health Care
What the data says
Profit Margin changed -2769% YoY in FY2024, a notable deviation from the 2-year average annual change of -1334%.
Based on SEC 10-K filings.
-345.4% in FY2024.
Improved from -892.4% to -345.4% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 146This company -345.4% Sector average -796.3%
▼
+56.6% above sector average
Key checks
Key Insights
- In FY2024, profit margin decreased 2768.9% year-over-year.
- Currently 450.9pp above the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -345.4% | -2768.9% |
| FY2023 | 12.9% | +101.5% |
| FY2022 | -892.4% | - |
| FY2021 | - | - |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026